Accessing the Chinese Market with a Localization Strategy

The biopharmaceutical market in China is growing rapidly, with a projected market size increase from US$48 billion in 2020 to $112 billion in 2025, driven by increasing healthcare needs, government support, and R&D investments. Regulatory reforms implemented by the National Medical Products Administration (NMPA), including the 2019 revision of the Drug Administration Law, prioritize innovative product approvals and domestic manufacturing.